Direct serum assay for cell-free Bmi-1 mRNA and its potential diagnostic and prognostic value for colorectal cancer

Clinical Cancer Research

Volumn 21, Issue 5, 2015, Pages 1225-1233

  Zhang, Xin ^a   Yang, Xiaoyun ^a   Zhang, Yanli ^b   Liu, Xinfeng ^b   Zheng, Guixi ^a   Yang, Yongmei ^a   Wang, Lili ^a   Du, Lutao ^a   Wang, Chuanxin ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BMI1 PROTEIN; CARCINOEMBRYONIC ANTIGEN; MESSENGER RNA; BMI1 PROTEIN, HUMAN; TUMOR MARKER;

ADENOMA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BMI 1 GENE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL TUMOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISTANT METASTASIS; ELECTROIMMUNOASSAY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MALE; OVERALL SURVIVAL; PILOT STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; VALIDATION PROCESS; BLOOD; CANCER GRADING; CANCER STAGING; COLORECTAL NEOPLASMS; GENETICS; METASTASIS; MIDDLE AGED; MORTALITY; POLYMERASE CHAIN REACTION; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; TUMOR VOLUME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; PILOT PROJECTS; POLYCOMB REPRESSIVE COMPLEX 1; POLYMERASE CHAIN REACTION; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; ROC CURVE; TUMOR BURDEN;

EID: 84928810050     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-1761     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival amongpersons with lung, colorectal, breast, or prostate cancer. Cancer 2014;120: 1290-314.
3. Duffy MJ, van Rossum LG, van Turenhout ST, Malminiemi O, Sturgeon C, Lamerz R, et al. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. Int J Cancer 2011;128:3-11.
4. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC III, Sontag S, et al. Improved fecalDNAtest for colorectal cancer screening. Clin Gastroenterol Hepatol 2007;5:111-7.
5. Steffen PA, Ringrose L. What are memories made of? How Polycomb and Trithorax proteins mediate epigenetic memory. Nat Rev Mol Cell Biol 2014;15:340-56.
6. Alkema MJ,Wiegant J, Raap AK, Berns A, van Lohuizen M. Characterization and chromosomal localization of the human proto-oncogene BMI-1.Hum Mol Genet 1993;2:1597-603.
7. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999;397:164-8.
8. Hayry V, Makinen LK, Atula T, Sariola H, Makitie A, Leivo I, et al. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br J Cancer 2011;102:892-7.
9. Zhao J, Luo XD, Da CL, Xin Y. Clinicopathological significance of B-cellspecific Moloney murine leukemia virus insertion site 1 expression in gastric carcinoma and its precancerous lesion. World J Gastroenterol 2009;15:2145-50.
10. Breuer RH, Snijders PJ, Sutedja GT, Sewalt RG, Otte AP, Postmus PE, et al. Expression of the p16(INK4a) gene product, methylation of the p16 (INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions. Lung cancer 2005;48:299-306.
11. Choy B, Bandla S, Xia Y, Tan D, Pennathur A, Luketich JD, et al. Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. BMC Gastroenterol 2012;12:146.
12. KangMK, Kim RH, Kim SJ, Yip FK, Shin KH, Dimri GP, et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer 2007;96:126-33.
13. Liu L, Andrews LG, Tollefsbol TO. Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death. Oncogene 2006;25: 4370-5.
14. Silva J, Garcia V,Garcia JM, Pena C, DominguezG,Diaz R, et al. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients. Breast Cancer Res 2007;9:R55.
15. Zhang X, Wang C, Wang L, Du L, Wang S, Zheng G, et al. Detection of circulating Bmi-1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer. Int J Cancer 2012;131: 165-72.
16. Xu W, Zhou H, Qian H, Bu X, Chen D, Gu H, et al. Combination of circulating CXCR4 and Bmi-1 mRNA in plasma: A potential novel tumor marker for gastric cancer. Mol Med Rep 2009;2:765-71.
17. Winawer S, Zauber A, Ho M, O'Brien M, Gottlieb L, Sternberg S, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329: 1977-81.
18. Burnett-Hartman A, Newcomb P, Phipps A, Passarelli M, Grady W, Upton M, et al. Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer. Am J Gastroenterol 2012;107:1213-9.
19. Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, Hoon DS. Direct serum assay formicroRNA-21 concentrations in early and advanced breast cancer. Clin Chem 2011;57:84-91.
20. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
21. Youden W. Index for rating diagnostic tests. Cancer 1950;3:32-5.
22. Garcia JM, Pena C, Garcia V, Dominguez G, Munoz C, Silva J, et al. Prognostic value of LISCH7 mRNA in plasma and tumor of colon cancer patients. Clin Cancer Res 2007;13:6351-8.
23. Terrin L, Rampazzo E, Pucciarelli S, Agostini M, Bertorelle R, Esposito G, et al. Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease. Clin Cancer Res 2008;14:7444-51.
24. Wang H, Zhang X, Wang L, Zheng G,DuL, Yang Y, et al. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer. J Surg Oncol 2014;109:574-9.
25. El-Hefnawy T, Raja S, Kelly L, Bigbee WL, Kirkwood JM, Luketich JD, et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem 2004;50:564-73.
26. Orozco AF, Lewis DE. Flow cytometric analysis of circulatingmicroparticles in plasma. Cytometry A 2010;77:502-14.
27. Garcia JM, Garcia V, Pena C, Dominguez G, Silva J, Diaz R, et al. Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched. RNA 2008;14:1424-32.
28. Bond JH. Clinical evidence for the adenoma-carcinoma sequence, and the management of patients with colorectal adenomas. SeminGastrointest Dis 2000;11:176-84.
29. Kim JH, Yoon SY, Kim CN, Joo JH, Moon SK, Choe IS, et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett 2004;203: 217-24.
30. Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 2008;40:915-20.
31. He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, et al. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Mol Med 2013; 18:1491-8.
32. Kreso A, van Galen P, Pedley NM, Lima-Fernandes E, FrelinC, Davis T, et al. Self-renewal as a therapeutic target in human colorectal cancer. Nat Med 2014;20:29-36.
33. Tateishi K, Ohta M, Kanai F, Guleng B, Tanaka Y, Asaoka Y, et al. Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract. Clin Cancer Res 2006;12:6960-6.
34. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004;64:5245-50.
35. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010;39:133-44.
36. Xu J, Chen Q, Zen K, Zhang C, Zhang Q. Synaptosomes secrete and uptake functionally active microRNAs via exocytosis and endocytosis pathways. J Neurochem 2013;124:15-25.
37. Baron J. Screening for cancer with molecular markers: progress comes with potential problems. Nat Rev Cancer 2012;12:368-71.